Cara Therapeutics, Inc. - COM (CARA)

Historical Portfolio Holders from Q1 2014 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
13.5M
Holdings value Q3 2024
$4.14M
Value change Q3 2024
-$1.03M
Grand Portfolio weight change Q3 2024
0%
Number of holders
64
Number of buys Q3 2024
11
Number of sells Q3 2024
-43
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 13.5M $4.14M -$1.03M $0.31 64
2024 Q2 17.7M $4.56M -$4.05M $0.26 76
2024 Q1 23.5M $21.4M -$427K $0.91 95
2023 Q4 24.4M $18.1M -$5.08M $0.74 108
2023 Q3 27.1M $45.6M -$6.59M $1.68 122
2023 Q2 29.3M $82.9M -$18.9M $2.83 132
2023 Q1 33.9M $166M -$5.48M $4.91 161
2022 Q4 34M $365M -$4.54M $10.74 162
2022 Q3 34.6M $324M -$2.13M $9.36 151
2022 Q2 34.8M $318M +$23.4M $9.13 167
2022 Q1 31.7M $386M +$16.6M $12.15 177
2021 Q4 30.3M $369M +$3.33M $12.18 176
2021 Q3 29.6M $457M +$1.9M $15.45 163
2021 Q2 29.6M $423M -$29.5M $14.27 162
2021 Q1 29.8M $648M +$3.24M $21.71 157
2020 Q4 29.9M $452M -$10.5M $15.13 146
2020 Q3 30.6M $390M +$7.88M $12.73 152
2020 Q2 29.9M $512M +$22.4M $17.10 139
2020 Q1 32.2M $425M +$9.27M $13.21 130
2019 Q4 31.4M $505M +$4.58M $16.11 147
2019 Q3 30.5M $558M +$81.4M $18.28 141
2019 Q2 26M $559M +$84.3M $21.50 123
2019 Q1 22.3M $438M -$26.6M $19.62 132
2018 Q4 24.3M $315M -$3.52M $13.00 129
2018 Q3 23.5M $562M +$111M $23.95 142
2018 Q2 18.8M $359M +$24.2M $19.15 124
2018 Q1 17.9M $222M +$8.9M $12.38 115
2017 Q4 13.7M $167M -$24.2M $12.24 120
2017 Q3 15.5M $213M -$11.6M $13.69 117
2017 Q2 19.9M $307M +$41M $15.39 124
2017 Q1 17M $310M +$96.9M $18.39 109
2016 Q4 13.8M $128M +$13M $9.29 98
2016 Q3 11.6M $96.9M +$6.09M $8.35 78
2016 Q2 12M $57.6M -$25.3M $4.81 64
2016 Q1 16.3M $102M -$43.5M $6.22 90
2015 Q4 19.6M $331M +$18.6M $16.86 93
2015 Q3 18.5M $265M +$91M $14.29 89
2015 Q2 11.9M $144M +$15.1M $12.15 73
2015 Q1 11.1M $112M +$13.4M $10.05 58
2014 Q4 9.22M $92.1M -$3.31M $9.97 54
2014 Q3 9.72M $81.5M +$5.57M $8.39 55
2014 Q2 8.77M $149M +$752K $17.02 48
2014 Q1 8.62M $160M +$160M $18.61 42